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ABSTRACT
The reverse transcription-polymerase chain reaction (RT.PCR) was used to determine the patterns of expression for several
growth factor ligand and receptor genes during ovine preimplantation development. Transcripts for insulin-like growth factor
(IGF)-I, IGF-II, and the receptors for insulin and IGF-I were detected throughout ovine preimplantation development from the
1-cell to the blastocyst stage. Transforming growth factor x (TGFa) transcripts were also detected throughout ovine preimplantation development. The mRNAs encoding basic fibroblast growth factor (bFGF) were detected in all stages of the ovine
preimplantation embryo, although the relative abundance of this transcript consistently decreased from the 1-cell to the blastocyst
stage, suggesting that it may represent a maternal transcript in early sheep embryos. Transcripts encoding ovine trophoblast
protein (oTP) were detected only within blastocyst-stage embryos. Primary ovine oviduct cell cultures express the transcripts
for IGF-II, IGF-I, TGFot, bFGF, TGFI1, and the receptors for insulin and IGF-I, suggesting that paracrine growth factor circuits
may exist between the oviduct epithelium and the early ovine embryo. Transcripts for insulin, epidermal growth factor (EGF),
and nerve growth factor (NGF) were not detected in any stage of the ovine preimplantation embryo or within the oviduct cell
preparations. The expression of growth factor transcripts very early in mammalian development would predict that these molecules fulfil a necessary role(s) in supporting the progression of early embryos through the preimplantation interval. Our future
efforts will be directed to understanding the nature of these putative regulatory pathways.

INTRODUCTION
It is possible to culture large proportions of mouse
preimplantation embryos through to the blastocyst stage in
relatively simple, defined salt solutions [1]. Similar culture
environments have not been fully characterized for embryos of other species (e.g., rabbit, hamster, cow, sheep,
pig), including the human [2, 3]. In these examples, culture
media are still commonly supplemented with poorly defined constituents from conditioned medium or serum [318]. Some preimplantation embryos require the additional
step of employing coculture on primary oviduct epithelial
cell monolayers [9-12,16-21]. However, in all cases, cultured mammalian embryos can be distinguished from their
in vivo counterparts by their morphology, reduced cell
number, impaired developmental rates, or lower pregnancy rates after embryo transfer (ET).
Recent efforts to characterize the appropriate molecular
milieu required to successfully support development through
the preimplantation interval in these species have focused

upon the role(s) of growth factors in early development
(for review see [22]). Growth factors play important roles
in modulating embryonic and fetal growth and development [22-44]. This influence can be demonstrated as early
as during the preimplantation interval, since physiological
levels of several growth factors have been shown to affect
murine development through increased protein and RNA
synthetic rates, increased rates of cell division, increased
cell number, and elevated blastocyst expansion and zona
hatching rates [25, 26, 28-40].
Much less is known about the possible role(s) of growth
factors in modulating early development in other, nonmurine, mammalian species [41-44]. We have demonstrated that bovine preimplantation embryos express a pool
of growth factor mRNAs similar to those present in the
mouse, but the stage-specific timing of expression for these
transcripts varies between these species [45, 46].
The present study extends our investigation of the patterns of expression for these growth factors to include ovine
preimplantation development. As in previous studies, the
method of mRNA phenotyping by the reverse transcriptionpolymerase chain reaction (RT-PCR) was employed to examine whether transcripts for the insulin-like growth factor
(IGF), epidermal growth factor (EGF), and transforming
growth factor (TGF) families were detectable during ovine
preimplantation development. The sheep represents an important model for the investigation of fetal development,
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and extensive research has shown that growth factors such
IGF-I and IGF-II play an essential role in regulating ovine
fetal growth (for review see [47]). It is therefore of interest
to investigate whether this growth factor-mediated influence is initiated during the preimplantation period. Our
analysis also characterizes the expression of these transcripts within primary oviduct epithelial cells to identify putative paracrine regulatory circuits between the oviduct and
the early embryo.
MATERIALS AND METHODS
In Vitro Maturation (IM) and In Vitro Fertilization(IVF)
of Ovine Oocyte Cumulus Complexes (OCC)
The methods outlined in Watson et al. [48] were employed in the production of preimplantation ovine embryos from follicular aspirates obtained from slaughterhouse ovaries. Ovarian follicles (2-8 mm) were aspirated
from slaughterhouse ovaries within 4 h of removal from
the animal. The OCC were pooled and washed a minimum
of six times with collection medium (TCM-199 medium
[Gibco, Grand Island, NY] + 2% [v/v] fetal bovine serum
[FBS; Gibco] and 100 IU/ml heparin [Sigma, St. Louis, MO]).
OCC were then placed into maturation medium (TCM-199
containing 10% [v/v] FBS supplemented with sodium pyruvate [35 Fpg/ml; Sigma], 5 ,ug/ml FSH [Follitropin; Vetrepharm, London, ON, Canada], 5 [ig/ml LH [Vetrepharm],
and 1 jig/ml estradiol-17[ [Sigma]) for 24 h at 38.6°C in a
humidified atmosphere containing 5% CO 2 in air [12].
For each insemination, frozen semen pellets were thawed
and processed for "swim-up" procedures by layering the
semen under 1 ml of prewarmed (38.6°C) Hepes-buffered
modified Tyrode's solution (without BSA [49]) supplemented with 2% (v/v) heat-inactivated sheep serum for 2
h at 38.60C. The OCC were removed from the maturation
medium and washed through 100-lI drops of Hepes-buffered modified Tyrode's solution (without BSA) supplemented with 2% (v/v) heat-inactivated sheep serum. OCC
were then allocated to pre-equilibrated fertilization drops
(50 OCC/300-,lA drop) consisting of modified bicarbonatebuffered Tyrode's medium supplemented with 2% (v/v)
sheep serum under light paraffin oil (BDH Inc., Toronto,
ON, Canada). After "swim-up," approximately 50 ,al (or 5075 x 103 motile spermatozoa) of sperm solution was added
per each fertilization drop. The sperm/OCC droplets were
incubated for 24 h at 38.6°C in a humidified 5% CO 2 atmosphere in air before removal of the remaining cumulus
cell investment; the zygotes were then placed on primary
ovine oviduct cell monolayers.
Oviduct Cell Monolayer Formation
All of the embryos utilized in the present study were
produced through use of embryo coculture on primary oviduct epithelial cell cultures. The methods employed in the

establishment of these cultures were as previously described [12,48]. Briefly, oviducts were trimmed of connective tissue prior to trypsin digestion (0.05% trypsin solution
in Ca 2+ -, Mg2+-free Hanks' balanced salt solution [HBSS;
Gibco]) at 38.6°C for 20 min. The contents of the lumen
were then squeezed into a small Petri dish (35 mm) with
a pair of forceps. The cells were washed four times with
HBSS and then resuspended in TCM-199 + 10% (v/v) FBS
before being plated into 24-well plates containing 1 ml of
TCM-199 + 10% FBS/well, at an approximate density of 1
x 106 cells per well.
Embryo coculture was maintained for a maximum of 8
days at 38.6C in a humidified atmosphere of 5% CO 2 in
air to allow for blastocyst formation to occur. The embryos
were moved to fresh primary 48-h oviduct epithelial cell
cultures every 48 h to optimize their developmental progress. In total, over 6000 preimplantation ovine embryos
representing a developmental series from 1-cell zygotes to
hatched blastocysts were utilized in the study.
RNA Extraction
Ovine zygotes (60-125) were pooled into one of the following groups: 1) zygotes; 2) 2-cell to 8-cell, early cleavage
stage embryos; 3) morulae (embryos with a minimum of
30 cells); and 4) blastocysts (early cavitation to fully expanded blastocysts). Total RNA was extracted from embryo
pools in the presence of 10 jIg of Escherichia coli transfer
RNA (Sigma) as previously described [27,45]. Embryos were
placed into 100 u1l of extraction buffer (0.2 M NaCl, 1 mM
EDTA, 25 mM Tris HCl, pH 7.4) and were vortexed with
equal volumes of phenol and chloroform:isoamyl alcohol.
After phase separation by centrifugation, the aqueous phase
was re-extracted with chloroform:isoamyl alcohol, centrifuged, and then precipitated with 95% ethanol. RNA pellets
were washed with 70% ethanol and suspended in 11 u1lof
sterile distilled water prior to reverse transcription into cDNA.
Total RNA was extracted from 48-h primary oviduct epithelial cell monolayers by lysis in guanidinium isothiocyanate
(Pharmacia, Quebec, PQ, Canada) followed by ultracentrifugation through CsTFA [50].
RT-PCR
RNA from embryos was reverse transcribed into cDNA
according to the protocol provided with the SUPERSCRIPT® RNase H-Reverse transcriptase kit (Gibco BRL,
Gaithersburg, MD). Briefly, 0.5 jig of oligo(dT) 12_18 primer
(Gibco BRL) was added to each suspended embryo RNA
0
sample prior to a 10-min incubation at 70 C. After this incubation, the RNA was reverse transcribed by combining
200 U of SUPERSCRIPT® (Gibco BRL) with 5-strength reaction buffer (250 mM Tris HCl [pH 8.3], 375 mM KCI, and
15 mM MgCI 2), 10 mM dithiothreitol (DTT; Gibco BRL), and
0.5 mM each of dATP, dCTP, dGTP, and dTTP (Pharmacia)
for an incubation at 43°C for 1 h. The reaction was termi-

GROWTH FACTOR EXPRESSION IN EARLY SHEEP EMBRYOS
nated by heating at 92°C for 5 min and quickly cooling on
ice. The cDNA sample was further diluted by the addition
of 30 1 of sterile distilled water before storage at -20°C
or immediate amplification by PCR
PCR [51] was performed as described previously
[23, 31, 45]. Aliquots of embryo cDNA (5 .l1)were amplified
with 1 U of Taq DNA Polymerase (Bresatec, Adelaide, Australia) in a final volume of 50 l1containing 10-strength Taq
reaction buffer (670 mM Tris HCI [pH 8.8], 166 mM
(NH 4 )2SO4 , 2 mg/ml gelatin, and 4.5% Triton X-100; Bresatec), 2 mm MgCI 2, 0.2 mM of each dNTP, and 1 M of
each sequence-specific primer. The mixture was overlaid
with mineral oil and then amplified by PCR for up to 40
cycles in a DNA thermal cycler (BioQuest DNA Thermal Cycler, Sydney, Australia); each cycle consisted of denaturation at 94°C for 1 min, re-annealing of primers to target
sequences at 55-60°C for 2 min, and primer extension at
72°C for 2 min. An aliquot of the PCR products was run on
2% agarose gels containing 0.5 g/ml of ethidium bromide, and the resulting amplified DNA fragments were
photographed.
PCR Primers

Primer pairs were obtained from the regional DNA synthesis Laboratory, University of Calgary with the exception
of the ovine IGF-I and IGF-II (oIGF-I; oIGF-II) primer pairs,
which were synthesized by the Department of Microbiology, University of Adelaide, Adelaide, South Australia. The
sequences of the primers used and the sizes of the expected PCR fragments were exactly as reported previously
[45] with the exception of the oIGF-I and oIGF-II primer
sets. The oIGF-I primer sequences target a region of the
oIGF-I cDNA near the 3' end of the molecule, result in an
amplified fragment of 261 bp, and represent the following
sequences: 1) 5'-CACATCCTCCTCGCATCTCTT-3' for the
upstream primer and 2) 5'-TTGAGAGGCGCACAGTACATC3' for the downstream primer [52]. The oIGF-II primer sequences target a region of the oIGF-II cDNA also near the
3' end of the molecule and result in an amplified fragment
of 318 bp. The sequences are 1) 5'-CTTCTACTTCAGCCGACCATC-3' for the upstream primer and 2) 5'TGACTCTTGGCCTCTCTGAGC-3' for the downstream primer
[53]. All of our PCR experiments included a control reaction
utilizing a set of primers designed to bracket an intron/
exon border of the rodent 0-actin gene [45,54]. This primer
pair can be used to detect the presence of both -actin
mRNA (cDNA) via the predicted 243-bp PCR fragment and
contaminating genomic DNA (if genomic DNA is present a
second fragment, larger than the one expected, will appear
due to the inclusion of the intervening sequences). Also,
the target sequence bracketed by these -actin primers is
2000 bp from the 3' end of the cDNA. Thus, detection of
a 3-actin PCR fragment also indicated that the reverse transcription of this transcript was virtually complete and that
it produced cDNAs of at least 2 kb in length.
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To confirm the identity of the PCR products, the amplified DNA fragments either were cut with an appropriate
diagnostic restriction enzyme (RE) according to the supplier's instructions or were transferred to a nylon membrane and probed with the appropriate sequence as previously described [31,45]. Probes were labeled in the
presence of -32P-dCTP (3000 Ci/mmol) to specific activities of approximately 5 x 109 cpm/pi-g by means of the PCR
reaction [55]. The mouse TGFa and TGFP1 DNA fragments
for amplification and labeling were derived from an RT-PCR
clone originally generated from 11.5-day mouse embryo RNA.
The insulin and IGF-I receptor cDNA clones used for probe
preparation have been described by Ullrich et al. [56] and
Telford et al. [31], respectively.
RESULTS

The sensitive technique of mRNA phenotyping by RT-PCR
was applied to total RNA samples isolated from pools of
staged in vitro-matured, in vitro-fertilized, and in vitro-cocultured (IVMFC) ovine preimplantation embryos. In this
manner we have searched for detectable levels of the transcripts encoding insulin, IGF-I, IGF-II, EGF, TGFa, basic fibroblast growth factor (bFGF), TGF031, ovine trophoblast
protein (oTP), and nerve growth factor (NGF) and also for
the insulin, IGF-I, and IGF-II receptor mRNAs during
preimplantation ovine development. The assays were repeated a minimum of six times with different pools of staged
embryos representing a total of 6000 embryos. Each reverse-transcribed embryo cDNA sample was tested with the
13-actin primers for the presence of contaminating genomic
DNA. Genomic actin sequences give rise to a PCR DNA band
larger (approximately 400 bp) than the expected 243-bp
band that is derived from f-actin mRNA (cDNA). No PCR
product for actin genomic DNA was detected in any of the
growth factor phenotyping RT-PCR assays.
Examples of PCR results are summarized in Figure 1,
*hich displays the typical pattern of expression for these
growth factor transcripts during preimplantation development. The expression pattern within 48-h primary oviduct
epithelial cell cultures is shown in Figure 2. Transcripts for
13-actin were detected within all of the embryo stages and
oviduct cell cultures. IGF-II expression was observed
throughout ovine preimplantation development and also
within oviduct cell cultures. The identity of the expected
318-bp PCR fragment was confirmed by subjecting the PCR
fragment to a diagnostic RE digest with the restriction enzyme Hpa II (Fig. 3A), which resulted in the cleavage of
the oIGF-II PCR fragment, as expected, into two equal halves
(158 and 160 bp). The expression of IGF-II receptor mRNA
was not detected within ovine preimplantation embryos or
within the 48-h oviduct epithelial cell RNA preparations. A
strong 186-bp IGF-II receptor fragment was amplified in
mouse ovary RNA preparations, suggesting that our PCR
primers were capable of amplifying the homologous IGF-
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FIG. 1. Detection of growth factor transcripts within ovine preimplantation embryo RNA transcription products. Each lane represents the growth factor
PCR products derived from the equivalent of 10 preimplantation embryos: (A) one-cell zygotes; (B) early cleavage stage embryos (2-cell to 8-cell stage);
(C) morulae (> 30 cell embryos); and (D) blastocysts (from early to fully expanded blastocoel cavities). Part of the total PCR product (20 tLI)was resolved
on 2% agarose gels along with 2 Lg of 1-kb DNA ladder (Gibco BRL; lanes marked M). The expected PCR fragments are: 1) 3-actin (243 bp), 2) olGF-II
(318 bp), 3) IGF-II-R (186 bp), 4) insulin (301 bp), 5) insulin-R (324 bp), 6) olGF-I (261 bp), 7) IGF-I-R (354 bp), 8) EGF (247 bp), 9) TGF(x (239 bp), 10) bFGF
(282 bp), 11) bTP (358 bp), and 12) NGF (401 bp).
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FIG. 2. Detection of growth factor transcripts within 48-h ovine oviduct epithelial cell cultures. Each lane represents the PCR product derived from
amplifying the cDNA aliquot produced from 100 ng of purified oviduct epithelial cell RNA. The PCR product (20 i1I)was resolved on 2% agarose gels along
with 2 pg of 1-kb DNA ladder (lane M). The PCR products are as follows: 1) -actin, 2) olGF-II, 3) IGF-II-R, 4) insulin, 5) insulin-R, 6) olGF-I, 7) IGF-I-R, 8)
EGF, 9) TGFa, 10) bFGF, 11) TGFp1 (244 bp), 12) bTP, and 13) NGF.

II receptor sequences. Insulin ligand expression was also
not detected within any of these ovine embryo stages or in
the oviduct cell preparations. It was, however, possible to
detect the expected 301-bp insulin DNA fragment in ovine
pancreatic cell RNA preparations (data not shown). The PCR
product corresponding to the 324-bp insulin receptor was
detected in all preimplantation embryo stages and also within
the 48-h oviduct cell cultures. The identity of this PCR fragment was confirmed by Southern blot analysis (Fig. 3B),
which consisted of transferring the PCR fragment to a nylon
membrane and then probing the blot by hybridization with
a radiolabeled human insulin receptor cDNA clone [56]. The
probe hybridizes to the insulin receptor PCR fragment and,
because of sequence similarity to the IGF-I receptor, also
cross-hybridizes with the latter product even at high-stringency washes. The hybridization is, however, specific for
these two products. IGF-I ligand mRNAs were detected from
the 1-cell stage to the blastocyst stage and also within the
oviduct cell cultures. The identity of the expected 261-bp
DNA fragment was confirmed by conducting an RE digest
of the PCR fragment with Hpa II; this resulted in the cleavage of the IGF-I PCR product, as expected, into two fragments of 214 bp and 47 bp (Fig. 3C). Transcripts for the
IGF-I receptor were also amplified from the 1-cell stage
through to the blastocyst stages of preimplantation development. Similarly, this transcript was also localized within
oviduct epithelial cell RNA preparations. The identity of this
354-bp DNA fragment was confirmed by blotting and hybridization with a mouse IGF-I receptor cDNA ([31]; Fig.
3D). In this case, the hybridization of the radiolabeled IGFI receptor probe was specific for the IGF-I receptor PCR
product when the blots were washed at high stringency (0.1-

strength saline-sodium citrate [SSC], 700C). Cross-hybridization with the insulin receptor PCR product was observed
as expected when washes were carried out under less stringent conditions.
The expression of EGF transcripts was not observed during early development or within the 48-h oviduct cell cultures, although the expected 247-bp DNA fragment was detected within murine and ovine ovary RNA preparations (data
not shown). The expression of TGFu was detected throughout ovine preimplantation development and also within
oviduct epithelial cell cultures. The PCR product was identified as a TGFot DNA fragment by blotting and hybridizing
with a radiolabeled mouse TGFot DNA probe (Fig. 3E).
Expression of bFGF was detected throughout ovine
preimplantation development and within the oviduct cell
RNA preparations. It was, however, observed to consistently
decline in its apparent abundance from the 1-cell to the
blastocyst stage. That the PCR fragment represented the bFGF
transcript was confirmed by subjecting a sample of the amplified product to an RE digest with Hinfl that resulted in
the cleavage of the bFGF fragment into the expected 138and 144-bp DNA cleavage products (Fig. 3F). The transcripts for TGF1 were detected throughout early development, although the product was very difficult to resolve
by RT-PCR (data not shown). It was however, clearly expressed within the 48-h epithelial cell cultures. The identity
of this PCR product was confirmed by specific hybridization
with a radiolabeled mouse TGF31 cDNA probe after membrane transfer (Fig. 3G).
As was expected, the transcripts for oTP were detected
only within the ovine blastocyst embryo cDNA preparations
and were never apparent within samples of embryos at ear-
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FIG. 3. Verification of growth factor RT-PCR products. PCR fragments for identification purposes were produced from ovine oviduct and preimplantation embryo cDNA preparations. In all cases (with the exception of the olGF-II and oIGF-I primer pairs, which are unique to this study), the PCR product
sizes were identical to those observed within murine and bovine preimplantation embryos [31, 451. A) The 318-bp olGF-II PCR product (small arrowhead)
was cleaved with Hpa II, which produced the expected 160- and 158-bp DNA fragments (large arrowhead) when run on a 2% agarose gel. M, markers; U,
uncut; C, cut. B) The 324-bp insulin receptor fragment (lane 1) was run together with the PCR products from the murine IGF-II-R (lane 2) and ovine IGFI-R (lane 3) before blotting and hybridization with, a radiolabeled insulin receptor cDNA clone [62]. The autoradiogram is shown next to the ethidium
bromide-stained gel and demonstrates that only the insulin receptor PCR product and the IGF-I receptor PCR product (which have similar sequences)
hybridize with the labeled probe. C) The 261-bp olGF-I DNA fragment (small arrowhead) was cleaved with Hpa II, producing the expected 214-bp (large
arrowhead) and 47-bp (not visible in figure) fragments when run on a 2% agarose gel. M, markers; U, uncut; C, cut. D) The 354-bp IGF-I receptor PCR
32
product (lane 1) was run along with the PCR products for IGF-II ligand (lane 2) and the insulin receptor (lane 3), blotted, and hybridized with a P-labeled
probe
hybridizes
specifically
to the
IGF-I receptor clone. The autoradiogram (adjacent to the ethidium bromide-stained gel) shows that the radiolabeled
IGF-I receptor lane. E) The 239-bp TGFa PCR fragment (lane 1) was run together with the TGFP1 (lane 2) and bFGF (lane 3) PCR products before blotting
and hybridization with a radiolabeled partial human TGFa cDNA clone. The autoradiogram (next to the ethidium bromide-stained gel) clearly shows that
only the TGFa lane is capable of hybridizing to the cDNA probe. F) The 282-bp bFGF PCR DNA fragment (small arrowhead) was cleaved with Hinf 1,
resulting in the expected 144- and 138-bp fragments (large arrowhead) when resolved on a 2% agarose gel. M, markers; U, uncut; C, cut. G) The 244-bp
TGF31 PCR product (lane 1) was resolved on an ethidium bromide-stained agarose gel along with the PCR products for bFGF (lane 2) and TGFt (lane 3)
before blotting and hybridization with a radiolabeled mouse TGFP1 cDNA probe. The autoradiogram (to the right of the gel) shows that only the TGF31
PCR product is capable of hybridizing to the cDNA probe. H) The 358-bp bTP PCR fragment (small arrowhead) was cleaved with Apa I, yielding the expected
190- and 168-bp DNA fragments (large arrowhead). M, markers; U, uncut; C, cut.
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lier stages or within the oviduct cell cDNA samples. The
identity of the oTP transcript was confirmed by cleaving the
oTP PCR product with the restriction enzyme Apa I to yield
the expected 190- and 168-bp products (Fig. 3H). The expected 401-bp DNA fragment for NGF was not detected
within any ovine embryo stage or within the oviduct cell
cultures. The primers did, however, successfully amplify the
appropriate NGF PCR product within liver and ovary RNA
preparations (data not shown).
DISCUSSION
In the study reported here, we detected the expression
of eight different growth factor ligand and receptor genes
during ovine preimplantation development and in primary
ovine oviduct epithelial cell cultures. These include IGF-II,
IGF-I, TGFt, bFGF, TGF31, oTP, insulin receptor, and IGFI receptor. With the exception of the oIGF-I, oIGF-II, and
oTP primer pairs, the oligonucleotide primers were designed through use of mouse or human cDNA sequences
[45]. Their effectiveness in amplifying specific ovine embryo cDNAs was assured in all cases by observing the expected size of the amplified DNA fragment and then either
cleaving with a diagnostic RE at a known sequence at the
correct site or blotting and hybridizing with the complementary mouse or human cDNA probe.
The expression patterns of growth factor mRNAs in early
ovine embryos are similar to those reported for other species. For example, transcripts for IGF-I ligand were detected throughout ovine preimplantation development just
as reported previously for oocytes and preimplantation embryos for both the rat [57] and cow [45]. Although IGF-I
transcripts were not observed in early studies on preimplantation mouse embryos [24], reexamination of IGF-I
expression in murine embryos has established that transcripts are detectable by RT-PCR from oocyte to blastocyst
stages in this species as well (R. Schultz, personal communication). IGF-I is an essential, direct regulator of ovine
fetal growth [47, 58]. It exerts this influence by a variety of
actions in many fetal cell types and tissues in vitro, including stimulation of cell proliferation, protein synthesis, glycogen synthesis, and differentiation (for review see [47]).
Basic FGF mRNAs were also detected within preimplantation ovine embryos. Although bFGF transcripts have not
been detected in preimplantation mouse embryos, kFGF
transcripts are present in early mouse embryos [24]. The
apparent accumulation of bFGF mRNA within both ovine
and bovine [45] 1- to 8-cell embryos would predict a possible maternal origin for these transcripts. However, even
when growth factor transcripts are expressed in common
between ovine and murine preimplantation embryos (as has
been observed for IGF-II, insulin receptor, IGF-I receptor,
and TGFfi1), there are differences in the stage-specific timing of appearance and thus possibly the origin (maternal
or embryonic) of the growth factor transcript [22-24, 45].
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The switch from maternal to embryonic control of preimplantation development (as measured by the onset of embryonic transcriptional activity) varies markedly among the
mammalian species, with a very early onset in the mouse
embryo at the 2-cell stage and a delayed initiation at the 816-cell stage in both the ovine and bovine embryo (for review see [59]). If we predict that a particular transcript is
likely to be of embryonic origin if it is not expressed prior
to the 2-cell stage in the mouse embryo, then the mRNAs
for IGF-II, insulin receptor, IGF-I receptor, and TGFPI1 would
all be products of the embryonic genome in the mouse but
would be products of both the maternal and embryonic
genomes in ovine and bovine embryos [45]. As in the mouse
and bovine preimplantation embryos, TGFoL expression was
detected throughout ovine preimplantation development
[23,45]. The mRNAs encoding EGF, NGF, and insulin have
not been detected during preimplantation development
within any of these mammalian species [22-24, 35, 45].
The apparent lack of expression for the IGF-II receptor
during ovine preimplantation development should be interpreted with caution: it was not pQssible to determine the
extent of homology of our murine primers with the oIGFII receptor sequences since the oIGF-II receptor has not to
our knowledge been clofied and sequenced. Therefore, it
was not possible to redesign new oIGF-II receptor oligodeoxynucleotide primer pairs and determine whether the
absence of expression was simply due to the use of nonhomologous primer pairs and thus poor efficiency in the
PCR reaction. This is the most probable explanation, since
transcripts for IGF-II receptor have been reported throughout bovine preimplantation development [45] and also in
the early mouse embryo as an embryonic transcript [2427]. Clarification of the ovine expression pattern for IGF-II
receptor must await the publication of the oIGF-II receptor
cDNA sequences.
Bovine and ovine trophoblast proteins (bTP; oTP) are
both classed as trophoblast interferons and play an important role in facilitating maternal recognition of pregnancy
[60-62]. The cDNAs for these molecules show a high degree of homology (> 85% identical), particularly in the 3'
untranslated regions (> 90%) [60]; thus it appears certain
that our bTP PCR primers have amplified an identical region of the oTP within the ovine blastocysts [62]. We investigated the expression of bTP/oTP within ovine preimplantation development to provide evidence that our in vitro
ovine blastocysts were capable of expressing this important
early molecular signal for the establishment of pregnancy.
In addition, failure to detect oTP transcripts until the blastocyst stage is precisely as expected, and this result contributes to the validity of these assays.
The expression of growth factor transcripts very early in
mammalian development would predict that these molecules fulfil a necessary role(s) in supporting the progression of early embryos throughout the preimplantation
interval. It is now clear that members of the IGF family
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(IGF-I, IGF-II, insulin), EGF family (EGF, TGFo), and TGF3
family collectively are involved in influencing a number of
events during early murine development; among these events
are RNA and protein synthesis, cleavage rates and embryo
cell number, and blastocoel expansion and proportion of
blastocysts hatching from the zona pellucida in vitro [2530, 32-39].
Growth factors also certainly play a role in facilitating
the early development of other mammalian species. When
TGF[ and bFGF are added to bovine embryo culture, up
to 38.8% of in vitro-fertilized zygotes progress beyond the
16-cell stage with 24.6% continuing on to the blastocyst stage
[41]. Furthermore, 39.1% of cleaved bovine zygotes can
progress beyond the 16-cell stage in medium supplemented with platelet-derived growth factor (PDGF), while
TGFot is effective in increasing the proportion of bovine
zygotes capable of undergoing blastocyst formation [42].
Similar studies have not yet been carried out on preimplantation ovine development, but the detection of growth
factor transcripts in early ovine embryos should support
such investigations.
The expression of transcripts for IGF-II, IGF-I, TGFa, bFGF,
and TGF[1 within 48-h ovine oviduct epithelial cell cultures extends our previous observations within bovine oviduct cell cultures [45] and further supports a role for the
oviduct in facilitating early mammalian development by the
establishment of paracrine growth factor circuits. Our future efforts will be directed to identifying the nature of these
putative regulatory pathways.
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